Could a simple protein boost stroke recovery? major trial underway
NCT ID NCT07263308
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving the protein albumin (given as an IV drip for four days) along with standard clot-removal treatment helps people recover better after a severe stroke caused by a large blockage. About 1,200 adults aged 18-80 with anterior circulation strokes will be enrolled. The main goal is to see if more people can live independently or return to their previous level of function 90 days later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Albumin (a protein given intravenously)
What this could lead to
If it works, this could provide a new, widely available treatment to improve recovery after a severe stroke.
What could go wrong
This is a large Phase 3 trial, but albumin has not been proven effective for stroke before. There is a risk of side effects like fluid overload or allergic reactions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Gansu Provincial Hospital
RECRUITINGLanzhou, Gansu, China
Contact
-
Jixi People's Hospital
RECRUITINGJixi, Heilongjiang, China
Contact
-
Laizhou People's Hospital
RECRUITINGYantai, Shandong, China
Contact
-
Ningling County People's Hospital
RECRUITINGShangqiu, Henan, China
Contact
-
Rizhao Hospital of Traditional Chinese Medicine
RECRUITINGRizhao, Shandong, China
Contact
-
Shanghai General Hospital Jiujuan Hospital
RECRUITINGJiuquan, Gansu, China
Contact
-
Si County People's Hospital
RECRUITINGSuzhou, Anhui, China
Contact
-
Taihe County Hospital of Traditional Chinese Medicine
RECRUITINGFuyang, Anhui, China
Contact
-
The First Affiliated Hospital of Henan University of Chinese Medicine
NOT_YET_RECRUITINGZhengzhou, Henan, China
-
The First Affiliated Hospital of Xinxiang Medical University
RECRUITINGWeihui, Henan, China
Contact
-
Xuanwu Hospital，Capital Medical University
RECRUITINGBeijing, Beijing Municipality, 100053, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Zhongmou County People's Hospital
RECRUITINGZhengzhou, Henan, China
Contact